MURIEL BOWSER
MAYOR
August 19, 2024
Honorable Phil Mendelson
Chairman
Council of the District of Columbia
John A. Wilson Building
1350 Pennsylvania Avenue, NW, Suite 504
Washington, DC 20004
Dear Chairman Mendelson:
Pursuant to Section 451 of the District of Columbia Home Rule Act (D.C. Official Code § 1-
204.51) and section 202 of the Procurement Practices Reform Act of 2010 (D.C. Official Code §
2-352.02), enclosed for consideration and approval by the Council of the District of Columbia is
proposed Modification No. M0003 to Contract No. CW101573 with AmerisourceBergen Drug
Corporation to exercise option year two in the not-to-exceed amount of $15,000,000. The period
of performance is October 1, 2024, through September 30, 2025.
Under the proposed modification, AmerisourceBergen Drug Corporation will continue to supply
pharmaceuticals to the Department of Health HIV/AIDS, Hepatitis, STD, and TB Administration
for its AIDS Drug Assistance Program and for its sexually transmitted diseases and tuberculosis
health and wellness clinical program.
My administration is available to discuss any questions you may have regarding the proposed
contract modification. In order to facilitate a response to any questions you may have, please have
your staff contact Marc Scott, Chief Operating Officer, Office of Contracting and Procurement, at
(202) 724-8759.
I look forward to the Council’s favorable consideration of this contract modification.
Sincerely,
Muriel Bowser
 GOVERNMENT OF THE DISTRICT OF COLUMBIA
Office of Contracting and Procurement
Pursuant to section 202(c-3) of the Procurement Practices Reform Act of 2010, as amended, D.C.
Official Code § 2-352.02(c-3), the following contract summary is provided:
COUNCIL CONTRACT SUMMARY
(Options)
(A) Contract Number: CW101573
Proposed Contractor: AmerisourceBergen Corporation
Contract Amount Not-to-Exceed (NTE) $15,000,000
Term of Contract: October 1, 2024 through September 30, 2025
Type of Contract: Requirements
(B) Identifying number of the underlying contract, including the identifiers assigned to the
underlying contract by the Council for the base period and any subsequent option periods:
Base Period Amount: NTE $15,000,000
Council Approval Number:
CA24-0667
Option Period One Amount: NTE $15,000,000
Council Approval Number:
CA25-0352
Option Period Two Amount: NTE $15,000,000
Option Period Three Amount: NTE $15,000,000
Option Period Four Amount: NTE $15,000,000
(C) A statement that Citywide Clean Hands database indicates that the proposed contractor is
current with its District taxes. If the Citywide Clean Hands Database indicates that the
proposed contractor is not current with its District taxes, either: (1) a certification that the
1
 contractor has worked out and is current with a payment schedule approved by the District;
or (2) a certification that the contractor will be current with its District taxes after the District
recovers any outstanding debt as provided under D.C. Official Code § 2-353.01(b):
The contractor’s Citywide Clean Hands report dated June 14, 2024, states that the contractor has no
outstanding liability with the District.
(D) A statement that the proposed contract is within the appropriated budget authority for the
agency for the fiscal year and is consistent with the financial plan and budget adopted in
accordance with D.C. Official Code §§ 47-392.01 and 47-392.02:
DC Health’s Agency Financial Officer has certified that funds for the proposed Council approval
action for the sum of $15,000,000 are available.
 Government of the District of Columbia
Office of the Chief Financial Officer 1101 4th Street, SW
Office of Tax and Revenue Washington, DC 20024
Date of Notice: June 14, 2024 Notice Number: L0011980323
AMERISOURCEBERGEN DRUG CORP FEIN: **-***3106
PO BOX 959 Case ID: 8947579
VALLEY FORGE PA 19482-0959
CERTIFICATE OF CLEAN HANDS
As reported in the Clean Hands system, the above referenced individual/entity has no outstanding
CO
liability with the District of Columbia Office of Tax and Revenue or the Department of Employment
Services. As of the date above, the individual/entity has complied with DC Code § 47-2862, therefore
this Certificate of Clean Hands is issued.
TITLE 47. TAXATION, LICENSING, PERMITS, ASSESSMENTS, AND FEES
CHAPTER 28 GENERAL LICENSE
SUBCHAPTER II. CLEAN HANDS BEFORE RECEIVING A LICENSE OR PERMIT
D.C. CODE § 47-2862 (2006)
PY
§ 47-2862 PROHIBITION AGAINST ISSUANCE OF LICENSE OR PERMIT
Authorized By Melinda Jenkins
Branch Chief, Collection and Enforcement Administration
To validate this certificate, please visit MyTax.DC.gov. On the MyTax DC homepage, click the
“Validate a Certificate of Clean Hands” hyperlink under the Clean Hands section.
1101 4th Street SW, Suite W270, Washington, DC 20024/Phone: (202) 724-5045/MyTax.DC.gov
 Government of the District of Columbia
Office of the Chief Financial Officer
Department of Health
MEMORANDUM
TO: Nancy Hapeman
Chief Procurement Officer
Office of Contracting and Procurement
THRU: Delicia V. Moore
Associate Chief Financial Officer
Human Services Support Cluster
FROM: Adreana Deane
Agency Fiscal Officer
Department of Health
DATE: July 2, 2024
SUBJECT: Certification of Funding Availability for Amerisource Bergen, Contract
#CW101573
The Office of the Chief Financial Officer hereby certifies that the sum of $15,000,000 is included in the
District’s Federal Grant Budget and Financial Plan for Fiscal Year 2025 to fund the costs associated with
the Department of Health’s contract with Amerisource Bergen to procure pharmaceuticals. This
certification supports the Amerisource Bergen contract during the period from October 1, 2024, to
September 30, 2025. The fund allocation is as follows:
Vendor: Amerisource Bergen Contract #: CW101573
Fiscal Year 2025 Funding Period: 10/01/24 to 03/31/25
FY Agency Fund Program Cost Account Award Project Task/Sub Amount
Code Center task
2025 HC0 4020002 700035 70079 7132001 2001608 200824 24.03 $7,100,000
Fiscal Year 2025 Funding Period: 04/1/25 to 09/30/25
FY Agency Fund Program Cost Account Award Project Task/Sub Amount
Code Center task
2025 HC0 4020002 700035 70079 7132001 2001810 200824 30.60 $7,100,000
2201 Shannon Place SE • 4th Floor • Washington, D.C. 20020 • Phone (202) 442-5955
 Fiscal Year 2025 Funding Period: 10/01/24 to 09/30/25
FY Agency Fund Program Cost Account Award Project Task/Sub Amount
Code Center task
2025 HC0 1060188 700041 70079 7132001 6000037 202184 30.40 $800,000
Total FY25 contract $15,000,000
Upon approval of the District’s Federal Budget and Financial Plan by the Council and the Mayor and
completion of the thirty-day Congressional layover, funds will be sufficient to pay for fees and costs
associated with the contract. Additional funds are anticipated to be available based on FY24 close
carryover and a new grant award starting in FY25. There is no fiscal impact associated with the contract.
Should you have any questions, please contact me at 202-442-9222.
2201 Shannon Place SE • 4th Floor • Washington, D.C. 20020 • Phone (202) 442-5955
AMENDMENT OF SOLICITATION / MODIFICATION OF CONTRACT 1. Contract Number Page of Pages
CW101573 1 1
2. Amendment/Modification Number: 3. Effective Date: 4. Requisition/Purchase Request No.: 5. Solicitation Caption:
MO003 See 16C DOH HAHSTA ADAP
Pharmaceutical Wholesaler
6. Issued by: Code MBDHC0 7. Administered by (If other than line 6):
Office of Contracting and Procurement (OCP) District of Columbia
On Behalf of DC Health Department of Health (DC Health)
899 North Capitol Street, NE HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA)
5th Floor, Suite 546 899 North Capitol Street, N.E. 4th Floor
Washington, DC 20002 Washington, DC 20002
8. Name and Address of Contractor (No. street, city, county, state and zip code) 9A. Amendment of Solicitation No.
AmerisourceBergen Drug Corporation
One West First Avenue 9B. Dated (See Item 11)
10A. Modification of Contract/Order No.
Conshohocken, PA 19428
X CW101573
10B. Dated (See Item 13)
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
The above numbered solicitation is amended as set forth in item 14. The hour and date specified for receipt of Offers is extended. is not extended.
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:
(a) By completing Items 8 and 15, and returning one (1) copy of the amendment: (b) By acknowledging receipt of this amendment on each copy of the offer submitted;
or (c) BY separate letter or fax which includes a reference to the solicitation and amendment number. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED
AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If
by virtue of this amendment you desire to change an offer already submitted, such may be made by letter or fax, provided each letter or telegram makes reference to the
solicitation and this amendment, and is received prior to the opening hour and date specified.
12. Accounting and Appropriation Data (If Required)
13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTORS/ORDERS, IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN
ITEM 14
A. This change order is issued pursuant to (Specify Authority): 27 DCMR, Chapter 36, Section 3601.2(b). The changes set forth in Item 14 are
made in the contract/order no. in item 10A.
B. The above numbered contract/order is modified to reflect the administrative changes (such as changes in paying office, appropriation data etc.)
set forth in item 14, pursuant to the authority of: 27 DCMR, chapter 36, Section 3601.2
C. This supplemental agreement is entered into pursuant to authority of: DC Official Code §2-354.04 and 27 DCMR
X D. Other (Specify type of modification and authority) 27DCMR, Section 3600
E. IMPORTANT: Contractor is not is required to sign this document and return one (1) copy to the issuing office.
14. Description of Amendment/Modification (Organized by UCF Section headings, including solicitation/contract subject matter where feasible)
The referenced contract is modified as follows:
1. Exercise Option Year Two pursuant to Section F.2 of the referenced contract. The period of performance is
from October 1, 2024, through September 30, 2025, in the amount not-to-exceed $15,000,000.
Except as provided herein, all terms and conditions of the document is referenced in Item 9A or 10A remain unchanged and in full force and effect.
15A. Name and Title of Signer (Type or print) 16A. Name of Contracting Officer
Monica Bailey Delissaint
15B. Name of Contractor 15C. Date Signed 16B. District of Columbia 16C. Date Signed
(Signature of person authorized to sign) (Signature of Contracting Officer)